Kesimpta (ofatumumab) for the Treatment of Relapsing Multiple Sclerosis (RMS)
Kesimpta is the first and only self-administered, targeted B-cell therapy for RMS. Credit: Novartis Pharma AG.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
-
MIT Optimal Sourcing Solutions
MIT Optimal Sourcing Solutions is a dedicated supplier of comparator...
About
MIT Optimal Sourcing Solutions is a dedicated supplier of comparator drugs, specialised in European Union (EU) open market solutions for clinical trials.
FollowMake an Enquiry
-
esqLABS
Founded in 2017, esqLABS provides platform technologies, software, consulting and...
About
Founded in 2017, esqLABS provides platform technologies, software, consulting and workshops for data analysis and model-based decision support throughout the healthcare industry.
FollowMake an Enquiry
-
Ika-Werke
The IKA Group manufactures a wide range of laboratory equipment...
About
The IKA Group manufactures a wide range of laboratory equipment and process technology, including stirrers, mixers, shakers, homogenisers, mills, rotary evaporators, calorimeters and laboratory analysis software.
FollowMake an Enquiry